FDIC Proposed Stablecoin Framework; 13% of Firms Report Actual Usage
The FDIC this week released its proposed rule under the GENIUS Act, tying stablecoin issuance to reserve integrity, liquidity discipline and custodial…
Lawsuits, patent wars, and enforcement actions.
The FDIC this week released its proposed rule under the GENIUS Act, tying stablecoin issuance to reserve integrity, liquidity discipline and custodial…
The CFTC named five senior advisors to its Innovation Task Force on April 10, setting up a formal rule-writing process for crypto assets, artificial…
Denis Beau, first deputy governor of the Bank of France, told EU policymakers at the Eurofi High Level Seminar on March 26 that the Markets in Crypto-Assets…
A Phoenix federal judge on Friday temporarily blocked Arizona from enforcing its gambling laws against federally regulated prediction markets.
A Connecticut federal judge ruled Mallinckrodt's Irish unit can't escape a state price-fixing suit after a five-year jurisdictional delay.
The FDIC proposed a 191-page Genius Act stablecoin rule Tuesday, its second under the Act.
The White House released its National Policy Framework for AI on March 20, 2026, calling on Congress to preempt state AI laws that "impose undue burdens.
FTC Chairman Ferguson warned PayPal, Stripe, Visa, and Mastercard that debanking customers on political grounds may violate the FTC Act.
Minnesota's attorney general is moving into a new phase of data privacy enforcement, signaling a shift in how the state approaches compliance obligations…
FinCEN and OFAC filed a joint proposed rule on April 8 to implement AML and sanctions compliance requirements for stablecoin issuers under the Genius Act.
FinCEN and OFAC issued a joint proposed rule on April 8 that would classify stablecoin issuers as financial institutions under the Bank Secrecy Act.
The Fed proposed replacing FedNow's two-bank transfer cap with an intermediary model, opening the platform to cross-border payments for the first time.
Acting Director Vought's plan would cut CFPB staff from 1,174 to 556 and reduce non-depository exams to 22 a year.
Trump's 100% Section 232 pharma tariffs exempt 13 drugmakers, generics, and trade-deal nations. Mid-sized biotechs are most at risk. Exemptions expire 2029.
The DOJ reversed course to back pharma in the 340B contract pharmacy dispute, leaving safety-net hospitals without a federal ally.
Trump signed an executive order imposing 100% tariffs on drug imports from countries without U.S. trade deals, effective within months.
You've reached the end of the archive.
Want the next stories in your inbox? Subscribe to the newsletter